368 related articles for article (PubMed ID: 36707869)
1. How does apolipoprotein E genotype influence the relationship between physical activity and Alzheimer's disease risk? A novel integrative model.
de Frutos Lucas J; Sewell KR; García-Colomo A; Markovic S; Erickson KI; Brown BM
Alzheimers Res Ther; 2023 Jan; 15(1):22. PubMed ID: 36707869
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
[TBL] [Abstract][Full Text] [Related]
4. Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum.
Liu Y; Tan L; Wang HF; Liu Y; Hao XK; Tan CC; Jiang T; Liu B; Zhang DQ; Yu JT;
Mol Neurobiol; 2016 Sep; 53(7):4539-47. PubMed ID: 26298664
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
[TBL] [Abstract][Full Text] [Related]
6. Roles of ApoE4 on the Pathogenesis in Alzheimer's Disease and the Potential Therapeutic Approaches.
Sun YY; Wang Z; Huang HC
Cell Mol Neurobiol; 2023 Oct; 43(7):3115-3136. PubMed ID: 37227619
[TBL] [Abstract][Full Text] [Related]
7. APOE-ε4 synergizes with sleep disruption to accelerate Aβ deposition and Aβ-associated tau seeding and spreading.
Wang C; Nambiar A; Strickland MR; Lee C; Parhizkar S; Moore AC; Musiek ES; Ulrich JD; Holtzman DM
J Clin Invest; 2023 Jul; 133(14):. PubMed ID: 37279069
[TBL] [Abstract][Full Text] [Related]
8. Effect of APOE ε4 genotype on amyloid-β and tau accumulation in Alzheimer's disease.
Baek MS; Cho H; Lee HS; Lee JH; Ryu YH; Lyoo CH
Alzheimers Res Ther; 2020 Oct; 12(1):140. PubMed ID: 33129364
[TBL] [Abstract][Full Text] [Related]
9. Independent and Interactive Influences of the APOE Genotype and Beta-Amyloid Burden on Cognitive Function in Mild Cognitive Impairment.
Seo EH; Kim SH; Park SH; Kang SH; Choo IH;
J Korean Med Sci; 2016 Feb; 31(2):286-95. PubMed ID: 26839485
[TBL] [Abstract][Full Text] [Related]
10. Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study.
Saddiki H; Fayosse A; Cognat E; Sabia S; Engelborghs S; Wallon D; Alexopoulos P; Blennow K; Zetterberg H; Parnetti L; Zerr I; Hermann P; Gabelle A; Boada M; Orellana A; de Rojas I; Lilamand M; Bjerke M; Van Broeckhoven C; Farotti L; Salvadori N; Diehl-Schmid J; Grimmer T; Hourregue C; Dugravot A; Nicolas G; Laplanche JL; Lehmann S; Bouaziz-Amar E; ; Hugon J; Tzourio C; Singh-Manoux A; Paquet C; Dumurgier J
PLoS Med; 2020 Aug; 17(8):e1003289. PubMed ID: 32817639
[TBL] [Abstract][Full Text] [Related]
11. The roles of apolipoprotein E ε4 on neuropathology and neuroinflammation in patients with Alzheimer's disease.
He M; Lian T; Guo P; Zhang W; Zhang Y; Huang Y; Liu G; Guan H; Li J; Luo D; Zhang W; Zhang W; Qi J; Yue H; Wang X; Zhang W
CNS Neurosci Ther; 2024 Mar; 30(3):e14440. PubMed ID: 37697966
[TBL] [Abstract][Full Text] [Related]
12. The Complex Role of Apolipoprotein E in Alzheimer's Disease: an Overview and Update.
Mahoney-Sanchez L; Belaidi AA; Bush AI; Ayton S
J Mol Neurosci; 2016 Nov; 60(3):325-335. PubMed ID: 27647307
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E isoforms and the development of low and high Braak stages of Alzheimer's disease-related lesions.
Ohm TG; Scharnagl H; März W; Bohl J
Acta Neuropathol; 1999 Sep; 98(3):273-80. PubMed ID: 10483785
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid β peptide.
Hashimoto T; Serrano-Pozo A; Hori Y; Adams KW; Takeda S; Banerji AO; Mitani A; Joyner D; Thyssen DH; Bacskai BJ; Frosch MP; Spires-Jones TL; Finn MB; Holtzman DM; Hyman BT
J Neurosci; 2012 Oct; 32(43):15181-92. PubMed ID: 23100439
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E epsilon4 does not modulate amyloid-β-associated neurodegeneration in preclinical Alzheimer disease.
Desikan RS; McEvoy LK; Holland D; Thompson WK; Brewer JB; Aisen PS; Andreassen OA; Hyman BT; Sperling RA; Dale AM;
AJNR Am J Neuroradiol; 2013 Mar; 34(3):505-10. PubMed ID: 22976236
[TBL] [Abstract][Full Text] [Related]
16. Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease.
Drzezga A; Grimmer T; Henriksen G; Mühlau M; Perneczky R; Miederer I; Praus C; Sorg C; Wohlschläger A; Riemenschneider M; Wester HJ; Foerstl H; Schwaiger M; Kurz A
Neurology; 2009 Apr; 72(17):1487-94. PubMed ID: 19339712
[TBL] [Abstract][Full Text] [Related]
17. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820
[TBL] [Abstract][Full Text] [Related]
18. Does the imbalance in the apolipoprotein E isoforms underlie the pathophysiological process of sporadic Alzheimer's disease?
Lozupone M; Imbimbo BP; Balducci C; Lo Vecchio F; Bisceglia P; Latino RR; Leone M; Dibello V; Solfrizzi V; Greco A; Daniele A; Watling M; Seripa D; Panza F
Alzheimers Dement; 2023 Jan; 19(1):353-368. PubMed ID: 35900209
[TBL] [Abstract][Full Text] [Related]
19. Neuropathology-based APOE genetic risk score better quantifies Alzheimer's risk.
Deming Y; Vasiljevic E; Morrow A; Miao J; Van Hulle C; Jonaitis E; Ma Y; Whitenack V; Kollmorgen G; Wild N; Suridjan I; Shaw LM; Asthana S; Carlsson CM; Johnson SC; Zetterberg H; Blennow K; Bendlin BB; Lu Q; Engelman CD;
Alzheimers Dement; 2023 Aug; 19(8):3406-3416. PubMed ID: 36795776
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E genotype regulates amyloid-beta cytotoxicity.
Wilhelmus MM; Otte-Höller I; Davis J; Van Nostrand WE; de Waal RM; Verbeek MM
J Neurosci; 2005 Apr; 25(14):3621-7. PubMed ID: 15814793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
